Subcutaneous
Subcutaneous technologies include drug depots, implantable sensors, ports and absorbable matrices that provide sustained pharmacokinetics, localized hemostatic or analgesic delivery, and minimally invasive physiologic monitoring. They reduce resupply burden and support delayed evacuation in austere and prolonged-field-care scenarios.
Technical Challenges
Variable absorption and efficacy during shock, hypoperfusion, or temperature extremes impacting pharmacokinetics.
Infection risk and biofilm formation on implants and ports in contaminated or prolonged-use settings.
Biocompatibility and foreign-body response limiting long-term sensor stability and depot tolerability.
Payload stability and cold-chain independence for biologics and vaccines in austere environments.
Emerging Opportunities
Thermostable, long-duration depot antibiotics, analgesics, and vaccines suitable for field use.
Subcutaneous sensors and coatings resistant to biofouling and motion artifact for continuous monitoring.
Rapidly deployable implantable hemostatic and analgesic depots for prehospital hemorrhage and pain control.
Validated manufacturing and regulatory pathways for field-adapted subcutaneous devices and combination products.
Current and Emerging Technologies in Subcutaneous
Biodegradable controlled‑release depots
Polymeric microspheres, hydrogels and implantable matrices engineered for sustained antibiotic, analgesic, or hemostatic release over days to weeks, minimizing repeat dosing in delayed-evacuation scenarios.
Implantable and minimally invasive sensors
Micro‑ and nano‑scale subcutaneous sensors for continuous monitoring of physiologic markers (glucose, lactate, infection biomarkers) with wireless telemetry for remote clinical decision support.
Wearable–subcutaneous hybrid platforms & ports
Low‑profile infusion ports, miniaturized programmable pumps, and adhesive interfaces that combine external control with subcutaneous reservoirs for prolonged and titratable therapy in forward-deployed settings.
Anti‑biofouling surfaces & bioactive coatings
Advanced coatings, antimicrobial eluting layers, and surface engineering to limit microbial colonization and inflammatory encapsulation, extending device lifetime and reducing infection risk.
Importance to Military Medicine
Enables prolonged-field care and delayed evacuation
Sustained subcutaneous therapeutics and ports permit ongoing care when definitive evacuation is delayed, reducing morbidity from hemorrhage, infection, and uncontrolled pain.
Supports force readiness via rapid prophylaxis
Depot vaccines and quick-deploy immunization platforms maintain unit health and mission capability during outbreaks or biological threats.
Optimizes care in austere environments
Robust subcutaneous devices reduce logistic burden, require less skilled maintenance, and provide remote monitoring capability for forward medical teams.
Reduces infection and complication rates when designed for field use
Biocompatible, anti‑biofilm solutions lower device-related infections and improve outcomes in contaminated combat environments.
Alignment with the MTEC Mission
Accelerates transition of military-relevant subcutaneous technologies from concept to deployment, matching MTEC’s DoD-focused mission.
Supports cross-disciplinary portfolio needs (combat casualty care, infectious disease, prolonged care) prioritized by MTEC.
Enables dual-use civilian benefits—vaccination platforms and chronic disease sensors—aligning with MTEC’s emphasis on broader public health impact.
Dual-Use (Military + Civilian) Applications
Battlefield hemostatic depots and local analgesic implants to control hemorrhage and pain when evacuation is delayed.
Thermostable depot vaccines and long-acting prophylactic antibiotics to sustain force health without complex cold chains.
Implantable sensors and ports for remote physiologic monitoring and delivery during prolonged field care or austere operations.
Civilian dual-use: chronic disease management (continuous glucose, infection surveillance) and perioperative sustained-release therapeutics.
Explore MTEC Members with Subcutaneous Capabilities
MTEC members bring complementary strengths—biomaterials research, device engineering, clinical trials, manufacturing scale-up, and regulatory expertise—to accelerate safe, field-ready subcutaneous solutions.
Collaborations between industry, academia, and military clinicians help validate performance in blast, polytrauma, and delayed-evacuation models, reducing time to operational use.
Explore member profiles to identify partners with expertise in depot formulation, implantable sensors, anti‑biofouling coatings, and field-ready device manufacturing.
99 Members with Subcutaneous capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Action Medical Technologies is a pharmaceutical and medical device company focused on developing innovative solutions that integrate medications with advanced devices and injector systems to improve patient outcomes, particularly in austere prehospital environments.
The University of Queensland (UQ) is one of Australia's leading research and teaching institutions, dedicated to transforming lives through education and research. UQ aims to create a better future by equipping students with the skills and knowledge necessary for their chosen careers, while also addressing some of the world's most complex challenges through innovative research.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Memsel is a biotechnology research and development company dedicated to enhancing health and combatting infections through advanced phage therapies and targeted delivery systems. The company aims to transform healthcare solutions across human, animal, and plant domains, addressing critical health challenges and antibiotic resistance.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
The Molinaroli College of Engineering and Computing at the University of South Carolina fosters innovation by preparing engineers and computing professionals to develop new technologies that will improve lives and the world. The college is committed to addressing real-world challenges through education, research, and community engagement.
Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.
Pneuma Systems Corporation specializes in designing and licensing closed-loop fluid control systems that precisely manage small fluid volumes without the complexity of traditional pumping mechanisms. The company leverages over 30 inventions and three novel subsystems to revolutionize fluid flow, workflow, information flow, and cash flow, aiming to transform the standard of care in infusion therapy. Pneuma is a small team of experienced medical device professionals working on a new technology platform for precise fluid delivery, with an emphasis on infusion therapy. Armed with a strong IP portfolio, Pneuma’s infusion controller is designed to support all venues of infusion therapy including acute care, standalone infusion centers, and home care. The design offers significant advances in fluid flow, information flow, and work flow. The design has been accepted into an accelerated review program by the U.S. Food and Drug Administration (FDA), known as STeP.
Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.
Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI